galactosamine has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Han, CK; Hyun, SH; In, G; Jung, HR; Kang, MJ; Kim, SW; Kyung, JS; Lee, YY; Moon, SJ; Park, CK; Yi, EC; Youn, SH | 1 |
Chapoval, AI; Nelson, H; Thibault, C | 1 |
2 other study(ies) available for galactosamine and B16 Melanoma
Article | Year |
---|---|
Biological Effects of Korean Red Ginseng Polysaccharides in Aged Rat Using Global Proteomic Approach.
Topics: Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Ginsenosides; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Panax; Phytotherapy; Plant Extracts; Polysaccharides; Protective Agents; Proteome; Rats; Rats, Sprague-Dawley; Spleen | 2020 |
Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.
Topics: Animals; Antibodies, Bispecific; Antigens, Neoplasm; Cytotoxicity, Immunologic; Female; Galactosamine; Humans; Immunoglobulin Fab Fragments; Immunotherapy; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Melanoma-Specific Antigens; Melanoma, Experimental; Mice; Mice, Inbred C3H; Muromonab-CD3; Neoplasm Proteins; Neoplasm Transplantation; Receptor-CD3 Complex, Antigen, T-Cell | 1995 |